ABOUT MEDABLE

Medable is on a mission to get effective therapies to people faster while expanding clinical research access to everybody, eliminating critical barriers to participation such as income status, geography, & race. Their next-generation AI-powered trial platform is built for speed, control, and global scale, with unmatched experiences for study teams, sites, and patients.

Founded by visionary CEO Dr. Michelle Longmire after discovering firsthand the difficulties of finding clinical operations, Medable’s platform is designed by a combination of physicians, patients, and tech experts to deliver true impact. The result is over 400 decentralized trials conducted across 70+ countries and 120+ locales with over 1 million patients supported globally.

A pioneer in patient-centric trials, Medable was ranked the number one provider of decentralized clinical trials (DCTs) and a Leader in eCOA by the Everest Group, they were awarded the Best Digital Health Solution by the Galien Foundation, and they recently collaborated with Tufts CSDD to release the first financial modeling showcasing the benefits of DCTs. Medable DCTs have now demonstrated net financial benefits of up to 5x & 14x greater than the initial upfront investment required for phase II & phase III studies, respectively.

Find out how Medable can partner with your organization to modernize research, replacing outdated processes with an intelligent, unified ecosystem of clinical trial technologies that slash timelines by >50%. Please visit www.Medable.com for further information.

FEATURED CONTENT

CONTACT INFORMATION

Medable

525 University Ave, Suite A70

Palo Alto, CA 94301

UNITED STATES

WEBINARS

FEATURED SOLUTIONS

  • Streamline your clinical trial study creation by automating and accelerating the eCOA build process. Generative AI models perform your repetitive configurations and significantly shorten build times.

  • Achieve unprecedented control over the study creation and deployment process with a no-code interface.

  • More than just a builder, Medable Studio offers unmatched control over study creation and launch, eliminating the common roadblocks of study startup and empowering users throughout the process.

  • Over the past year, this author has collaborated closely with a diverse team of clinicians and research experts to enhance Medable's research methodologies across various therapeutic domains.

  • Increased outreach, heightened involvement, superior quality. Tour this comprehensive consent management solution that enhances participant access and improves the overall patient experience.

  • Stay connected with your patients and their data by simplifying collection for sites and sponsors while keeping participants safe, comfortable, and engaged from any location.

  • Learn about our mission of making clinical trials easy to participate in around the world, as well as what Medable can do for you, with this overview. 

  • Accelerate research and drive operational efficiencies with multi-modal, scalable digital solutions for oncology, vaccine, and cardiovascular / metabolic studies.

  • Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.

  • Medable eCOA is designed to enhance your decentralized trial capabilities with all features native to the platform. Modular by design, use what you need, not what you don’t.

  • Learn how to optimize patient access to clinical research with a modern eConsent platform that delivers an engaging, flexible and scalable user experience.

  • Limited access to clinical trials has had a direct impact on the development of new medicines. Explore Medable's vision to open scientific research to the world using a platform designed for everybody, every biology, everywhere.

  • Examine this factsheet to see how Medable’s oncology offering simplifies data collection for sites and sponsors while keeping patients safe, comfortable, and engaged from any location.